Atlas Trials

A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer

Clinical trial NCT02753309 · COMPLETED

Trial details

NCT number
NCT02753309
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2016-06-01
Primary completion
2019-12-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.